Related Experiment Video
Updated: Apr 26, 2026

Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation
Published on: May 31, 2016
RANKL-OPG and RAGE modulation in vascular calcification and diabetes: novel targets for therapy
Agbor Ndip1, Fiona L Wilkinson, Edward B Jude
1Department of Medicine and Diabetes, Manchester Royal Infirmary, Manchester, UK, agbor.ako@manchester.ac.uk.
Abstract:
Type 2 diabetes is associated with increased cardiovascular morbidity and mortality and early vascular ageing. This takes the form of atherosclerosis, with progressive vascular calcification being a major complication in the pathogenesis of this disease. Current research and drug targets in diabetes have hitherto focused on atherosclerosis, but vascular calcification is now recognised as an independent predictor of cardiovascular morbidity and mortality. An emerging regulatory pathway for vascular calcification in diabetes involves the receptor activator for nuclear factor κB (RANK), RANK ligand (RANKL) and osteoprotegerin (OPG). Important novel biomarkers of calcification are related to levels of glycation and inflammation in diabetes. Several therapeutic strategies could have advantageous effects on the vasculature in patients with diabetes, including targeting the RANKL and receptor for AGE (RAGE) signalling pathways, since there has been little success-at least in macrovascular outcomes-with conventional glucose-lowering therapy. There is substantial and relevant clinical and basic science evidence to suggest that modulating RANKL-RANK-OPG signalling, RAGE signalling and the associated proinflammatory milieu alters the natural course of cardiovascular complications and outcomes in people with diabetes. However, further research is critically needed to understand the precise mechanisms underpinning these pathways, in order to translate the anti-calcification strategies into patient benefit.
Insights
Type 2 diabetes accelerates vascular aging and calcification, increasing cardiovascular risk. Targeting pathways like RANKL-RANK-OPG and RAGE shows promise for new therapies beyond glucose control.
Area of Science:
- Cardiovascular Science
- Endocrinology
- Vascular Biology
Background:
- Type 2 diabetes (T2D) is linked to heightened cardiovascular disease (CVD) risk and premature vascular aging.
- Vascular calcification, a key feature of atherosclerosis, independently predicts CVD morbidity and mortality in T2D patients.
- Conventional glucose-lowering therapies have limited success in improving macrovascular outcomes in T2D.
Purpose of the Study:
- To explore emerging regulatory pathways involved in vascular calcification in T2D.
- To identify novel biomarkers and therapeutic targets for T2D-associated vascular complications.
- To evaluate the potential of targeting specific signaling pathways for improved cardiovascular outcomes.
Main Methods:
- Review of current clinical and basic science evidence on vascular calcification in T2D.
- Analysis of the roles of the receptor activator of nuclear factor kappa B (RANK), RANK ligand (RANKL), and osteoprotegerin (OPG) pathways.
- Investigation of the receptor for advanced glycation end products (RAGE) signaling and inflammatory markers.
Main Results:
- The RANK-RANKL-OPG system is identified as a key regulatory pathway in diabetic vascular calcification.
- Glycation and inflammation levels serve as important biomarkers for vascular calcification in diabetes.
- Targeting RANKL and RAGE signaling pathways presents potential therapeutic strategies.
Conclusions:
- Modulating RANKL-RANK-OPG signaling, RAGE signaling, and the inflammatory environment may alter the course of cardiovascular complications in T2D.
- Novel therapeutic strategies targeting these pathways could offer benefits beyond conventional glucose management.
- Further research is essential to elucidate precise mechanisms and translate these findings into clinical benefits for patients.
More Related Videos
Related Concept Videos
Diabetic Retinopathy
Diabetic Nephropathy
Osteoclasts in Bone Remodeling

